TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3018363

Group type: EXPERIMENTAL
Intervention: Vitamin E (Group II)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Group I)
Number of subjects: 30
Study: 30175329

Group type: EXPERIMENTAL
Intervention: SRP plus omega-3 fatty acids supplementation
Number of subjects: 50

Group type: COMPARATOR
Intervention: SRP alone (control group)
Number of subjects: 50
Study: 26656289

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 24376099

Group type: EXPERIMENTAL
Intervention: Atomoxetine 40mg/day, titrated to a maximum of 120mg/day
Number of subjects: 233
Study: 22267751

Group type: EXPERIMENTAL
Intervention: Irbesartan (up to 300 mg daily)
Number of subjects: 3605

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3605
Study: 20363812

Group type: EXPERIMENTAL
Intervention: Rear-view camera and sensor system-based parking aid
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no rear-view camera and sensor system)
Number of subjects: 46
Study: 18547413

Group type: EXPERIMENTAL
Intervention: Childbirth classes for public health nurses (PHN)
Number of subjects: 1601

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1601
Study: 16902231

Group type: EXPERIMENTAL
Intervention: Motion control shoes (New Balance 1122)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cushion trainer shoes (New Balance 1022)
Number of subjects: 40
Study: 12492668

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 60

Group type: COMPARATOR
Intervention: PAXpress
Number of subjects: 60
Study: 11121979

Group type: EXPERIMENTAL
Intervention: Biofiltration (BF)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Bicarbonate hemodialysis (BcHD)
Number of subjects: 5
Study: 8730004

Group type: EXPERIMENTAL
Intervention: Low-dose theophylline
Number of subjects: 17
Study: 1686746

Group type: EXPERIMENTAL
Intervention: dilevalol (200 mg, 400 mg or 600 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 28
Study: 6134547

Group type: EXPERIMENTAL
Intervention: Intramuscular papaveretum
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral temazepam
Number of subjects: 100
Study: 31774519

Group type: EXPERIMENTAL
Intervention: Immediate intervention group
Number of subjects: 448

Group type: COMPARATOR
Intervention: Delayed intervention group
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Immediate intervention group (nonmetropolitan)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Delayed intervention group (nonmetropolitan)
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Immediate intervention group (missing teeth)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Delayed intervention group (missing teeth)
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Immediate intervention group (percentage of missing teeth > 0)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Delayed intervention group (percentage of missing teeth > 0)
Number of subjects: 448
Study: 29952047

Group type: EXPERIMENTAL
Intervention: Supportive-expressive (SE) group intervention
Number of subjects: 161

Group type: COMPARATOR
Intervention: Standard risk-counseling (RC)
Number of subjects: 161
Study: 25959424

Group type: EXPERIMENTAL
Intervention: Comprehensive Voice Rehabilitation Program (CVRP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vocal Function Exercises (VFE)
Number of subjects: 80
Study: 24457315

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy with helical tomotherapy (HT‐SBRT)
Number of subjects: 30
Study: 22752859

Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 0
Study: 21036667

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim
Number of subjects: 64

Group type: COMPARATOR
Intervention: G-CSF
Number of subjects: 64
Study: 17616473

Group type: EXPERIMENTAL
Intervention: Intravenous valproate (IV VA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous phenytoin (IV phenytoin)
Number of subjects: 100
Study: 15923119

Group type: EXPERIMENTAL
Intervention: Supra-aortic gastro-esophageal anastomosis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sub-aortic gastro-esophageal anastomosis
Number of subjects: 60
Study: 12418118

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Propranolol 40-80 mg
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Trimetazidine 20 mg
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Combination of Propranolol 40 mg and Trimetazidine 20 mg
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Propranolol 120 mg/day
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Trimetazidine 60 mg/day
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Combination of Propranolol 120 mg/day and Trimetazidine 60 mg/day
Number of subjects: 147

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Combined use of Propranolol and Trimetazidine
Number of subjects: 147
Study: 10613408

Group type: EXPERIMENTAL
Intervention: Plant stanol ester (3 grams daily from three servings of spread containing one gram of plant stanols each)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wheat bran fiber (5 grams for the first two weeks, then 10 grams for the second two weeks)
Number of subjects: 0
Study: 8564625

Group type: EXPERIMENTAL
Intervention: Bitolterol mesylate metered-dose inhaler (1, 2, or 3 inhalations)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (double-blind, randomized)
Number of subjects: 46
Study: 1834587

Group type: EXPERIMENTAL
Intervention: Fish oil diet (N-3 fatty acids)
Number of subjects: 12
Study: 6749458

Group type: EXPERIMENTAL
Intervention: Intravenous branched-chain amino acid solutions in 20% glucose (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lactulose plus glucose in isocaloric amount (group B)
Number of subjects: 40
Study: 31669427

Group type: EXPERIMENTAL
Intervention: Routine blood parameters (platelet count, CRP levels, GMI) during antifungal treatment
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Platelet count increase
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: CRP drop
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Platelet count increase in CAS cohort
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: GMI drop
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: ROC analysis for survival
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Baseline platelet count
Number of subjects: 374
Study: 29880220

Group type: EXPERIMENTAL
Intervention: Stress immediately before learning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stress 30 minutes before learning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stress (timing independent) in non-carriers of the BclI polymorphism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stress (timing independent) in carriers of the BclI polymorphism
Number of subjects: 0
Study: 29061616

Group type: EXPERIMENTAL
Intervention: CBT‐TLIF
Number of subjects: 254

Group type: COMPARATOR
Intervention: PS‐TLIF
Number of subjects: 254
Study: 25725903

Group type: EXPERIMENTAL
Intervention: 8-week exercise program with elastic bands, twice a week
Number of subjects: 51

Group type: COMPARATOR
Intervention: Walking programme (control)
Number of subjects: 51
Study: 24297587

Group type: EXPERIMENTAL
Intervention: Early post-surgical radiation therapy (within 3 months)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Late post-surgical radiation therapy (at disease progression)
Number of subjects: 95
Study: 21098003

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (Bicarb, 1 M; 350‐500 ml)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Normal saline (Sal)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (Bicarb)
Number of subjects: 6
Study: 19179918

Group type: EXPERIMENTAL
Intervention: rhBMP-2/ACS
Number of subjects: 102

Group type: COMPARATOR
Intervention: ICBG
Number of subjects: 102
Study: 17317757

Group type: EXPERIMENTAL
Intervention: Sevoflurane combined with dolasetron (SD)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Propofol-based total intravenous anaesthesia (TIVA)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Both TIVA and dolasetron prophylaxis
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Type of anaesthetic (TIVA vs SD)
Number of subjects: 126
Study: 15383105

Group type: EXPERIMENTAL
Intervention: Neurokinin B plasma levels in pre-eclamptic patients
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Neurokinin B plasma levels in IUGR patients
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nitric oxide metabolites levels in pre-eclamptic patients
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nitric oxide metabolites levels in IUGR patients
Number of subjects: 90

Group type: COMPARATOR
Intervention: Correlation between neurokinin B plasma values and nitric oxide metabolite levels in pre-eclampsia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Correlation between neurokinin B plasma values and nitric oxide metabolite levels in IUGR
Number of subjects: 90

Group type: COMPARATOR
Intervention: Correlation between neurokinin B plasma values and nitric oxide metabolite levels in controls
Number of subjects: 90
Study: 11291422

Group type: EXPERIMENTAL
Intervention: Whistle Watch (WW) device
Number of subjects: 80

Group type: COMPARATOR
Intervention: Patient's perceived symptomatology
Number of subjects: 80
Study: 9433615

Group type: EXPERIMENTAL
Intervention: Affected third-degree relatives method (cousins method - CM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulated extended family data set
Number of subjects: 0
Study: 8239161

Group type: EXPERIMENTAL
Intervention: Budesonide (200 micrograms 3 times/day) continued for 6 months
Number of subjects: 28

Group type: COMPARATOR
Intervention: Budesonide tapering-off (decrease dose within 2 months, followed by placebo for 4 months)
Number of subjects: 28
Study: 3159162

Group type: EXPERIMENTAL
Intervention: Miconazole 2% + benzoyl peroxide 5% (Acnidazil) applied twice a day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Benzoyl peroxide 5%
Number of subjects: 60
Study: 30352035

Group type: EXPERIMENTAL
Intervention: Yoga intervention (IAYT training for 14 weeks, 1.5 hours daily for 5 days a week)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no yoga activity, only walking)
Number of subjects: 72
Study: 27829371

Group type: EXPERIMENTAL
Intervention: Consolidation therapy
Number of subjects: 0
Study: 24867391

Group type: EXPERIMENTAL
Intervention: Perampanel (12 mg/day or individual maximum tolerated dose)
Number of subjects: 1216
Study: 23528509

Group type: EXPERIMENTAL
Intervention: Technology-based interventions for unintentional injury prevention
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Technology-based interventions for smoking cessation
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Technology-based interventions for risky behaviors
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Technology-based interventions for various risky behaviors
Number of subjects: 234
Study: 20373477

Group type: EXPERIMENTAL
Intervention: Clozapine, Olanzapine, Haloperidol, Risperidone (antipsychotics)
Number of subjects: 154
Study: 18958158

Group type: EXPERIMENTAL
Intervention: Angry faces
Number of subjects: 0

Group type: COMPARATOR
Intervention: Happy faces
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral faces
Number of subjects: 0
Study: 16882633

Group type: EXPERIMENTAL
Intervention: Complex training (dynamic constant external resistance and plyometrics), performed three times a week for 12 weeks.
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 54
Study: 12795581

Group type: EXPERIMENTAL
Intervention: Family Bereavement Program (FBP)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Self-study condition
Number of subjects: 244
Study: 10958716

Group type: EXPERIMENTAL
Intervention: 25 mg sildenafil
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 50 mg sildenafil
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 8712189

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 190
Study: 1282465

Group type: EXPERIMENTAL
Intervention: Loxiglumide (10 mg kg‐1 h‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atropine (5 micrograms kg‐1 h‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CCK8 (graded doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no specific control mentioned)
Number of subjects: 0
Study: 6771979

Group type: EXPERIMENTAL
Intervention: Combined film-screen/xeromammography
Number of subjects: 53

Group type: COMPARATOR
Intervention: Mediolateral noncontact xeromammogram
Number of subjects: 53

Group type: COMPARATOR
Intervention: Mediolateral and craniocaudal film-screen mammograms
Number of subjects: 53

Group type: COMPARATOR
Intervention: Xeromammography
Number of subjects: 53

Group type: COMPARATOR
Intervention: Film-screen mammography
Number of subjects: 53
Study: 30466808

Group type: EXPERIMENTAL
Intervention: Psychotropic medications (antidepressants and anxiolytics)
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Antidepressants (pre-existing prescriptions)
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Antidepressants (new prescriptions perioperatively)
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Sociodemographic and clinical characteristics
Number of subjects: 719
Study: 29026292

Group type: EXPERIMENTAL
Intervention: Holistic health group intervention (10 sessions, 90 minutes each, once per week)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (standardized basic educational materials)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Holistic health group intervention
Number of subjects: 38
Study: 26481873

Group type: EXPERIMENTAL
Intervention: Telehealth intervention (remote monitoring/management of chemotherapy side-effects) in addition to 'Usual Care'.
Number of subjects: 222

Group type: COMPARATOR
Intervention: Usual Care (control group).
Number of subjects: 222
Study: 23324454

Group type: EXPERIMENTAL
Intervention: Large-balloon dilation (LBD) alone
Number of subjects: 131

Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (EST) plus large-balloon dilation (LBD)
Number of subjects: 131
Study: 21248294

Group type: EXPERIMENTAL
Intervention: Individuals with insulin resistance (IR)
Number of subjects: 2418

Group type: EXPERIMENTAL
Intervention: Individuals without CKD
Number of subjects: 2418

Group type: EXPERIMENTAL
Intervention: Individuals with CKD
Number of subjects: 2418

Group type: EXPERIMENTAL
Intervention: Adiponectin
Number of subjects: 2418
Study: 19582244

Group type: EXPERIMENTAL
Intervention: Dexamucobase
Number of subjects: 53

Group type: COMPARATOR
Intervention: Kenalog in Orabase
Number of subjects: 53
Study: 17694693

Group type: EXPERIMENTAL
Intervention: Group education for children alone
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Group education for both children and caregivers
Number of subjects: 245

Group type: COMPARATOR
Intervention: Group education for caregivers alone
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 245
Study: 17190936

Group type: EXPERIMENTAL
Intervention: Estradiol gel
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 12691336

Group type: EXPERIMENTAL
Intervention: Exercise twice a week
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Lumbar lifting test
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Cervical lifting test
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Cervical lifting test and gait test with burden
Number of subjects: 231

Group type: COMPARATOR
Intervention: High-rated pain behaviour and perceived high pain intensity
Number of subjects: 231
Study: 10608530

Group type: EXPERIMENTAL
Intervention: Vascular control
Number of subjects: 56

Group type: COMPARATOR
Intervention: No vascular control
Number of subjects: 56
Study: 7862216

Group type: EXPERIMENTAL
Intervention: Paclitaxel 135 mg/m2
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Paclitaxel (both dosages)
Number of subjects: 55
Study: 2287558

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Aspirin 1000 mg
Number of subjects: 350

Group type: COMPARATOR
Intervention: Caffeine 65 mg
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg + Caffeine 65 mg
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study: 6117516

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mepindolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol (controls)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blockade (hypertensives)
Number of subjects: 0
Study: 29442087

Group type: EXPERIMENTAL
Intervention: Profluorid Varnish (Voco: Cuxhaven Germany)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Admira Protect (Voco: Cuxhaven Germany)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: PRG‐Barrier Coat (Shofu: Japan)
Number of subjects: 28
Study: 26647424

Group type: COMPARATOR
Intervention: Cinacalcet
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Subtotal parathyroidectomy
Number of subjects: 30
Study: 25701373

Group type: EXPERIMENTAL
Intervention: De novo low-dose tacrolimus/sirolimus (lowTAC/SIR)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Full-dose tacrolimus/mycophenolate mofetil (TAC/MMF)
Number of subjects: 126
Study: 24310737

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 20495102

Group type: EXPERIMENTAL
Intervention: Project ALERT intervention
Number of subjects: 34
Study: 18636790

Group type: EXPERIMENTAL
Intervention: Efalizumab 1 mg/kg/wk for 48 weeks
Number of subjects: 686

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 686
Study: 15983125

Group type: EXPERIMENTAL
Intervention: Fatigue exercise
Number of subjects: 20
Study: 12610022

Group type: EXPERIMENTAL
Intervention: Losartan and conventional antihypertensive therapy (CT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo and conventional antihypertensive therapy (CT)
Number of subjects: 0
Study: 10507209

Group type: EXPERIMENTAL
Intervention: One-Step (OS, Bisco)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single Bond (SB, 3M)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clearfil Liner Bond II (LBII, Kuraray)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tokuso Mac Bond II (MBII, Tokuso)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ground enamel surfaces (control group)
Number of subjects: 0
Study: 7815233

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant (Exosurf Neonatal)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant
Number of subjects: 419
Study: 1952132

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 97

Group type: COMPARATOR
Intervention: saline solution (control)
Number of subjects: 97
Study: 7034642

Group type: EXPERIMENTAL
Intervention: Amoxicillin plus clavulanic acid
Number of subjects: 22

Group type: COMPARATOR
Intervention: Amoxicillin only
Number of subjects: 22
Study: 31330465

Group type: EXPERIMENTAL
Intervention: Substance use screening (n=14)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Physical activity questionnaire (n=15)
Number of subjects: 29
Study: 28384735

Group type: EXPERIMENTAL
Intervention: Multivitamin (Centrum Silver)
Number of subjects: 13616

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13616

Group type: EXPERIMENTAL
Intervention: Multivitamin
Number of subjects: 13616
Study: 25918454

Group type: EXPERIMENTAL
Intervention: Valsartan/Hydrochlorothiazide
Number of subjects: 153

Group type: COMPARATOR
Intervention: Amlodipine/Benazepril
Number of subjects: 153
Study: 23416438

Group type: EXPERIMENTAL
Intervention: Gracilis muscle transfer neurotized to cross-facial nerve graft (group I, n=20)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Gracilis muscle transfer neurotized to ipsilateral masseteric nerve (group II, n=27)
Number of subjects: 47
Study: 21836044

Group type: COMPARATOR
Intervention: Endurance exercise (E)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Endurance exercise followed by resistance exercise (ER)
Number of subjects: 10
Study: 18823361

Group type: EXPERIMENTAL
Intervention: Fixed combination of acetylsalicylic acid + paracetamol + caffeine
Number of subjects: 1734

Group type: COMPARATOR
Intervention: Combination without caffeine
Number of subjects: 1734

Group type: COMPARATOR
Intervention: Single preparations
Number of subjects: 1734

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1734
Study: 17826421

Group type: EXPERIMENTAL
Intervention: Repeated doses of antenatal corticosteroids (R-ACS)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Single course of antenatal corticosteroids followed by placebo (S-ACS)
Number of subjects: 194
Study: 14713401

Group type: EXPERIMENTAL
Intervention: Glucosamine therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 10968496

Group type: EXPERIMENTAL
Intervention: 3,200 microg budesonide daily for 8 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: 1,600 microg budesonide daily for 8 weeks
Number of subjects: 61
Study: 9280188

Group type: EXPERIMENTAL
Intervention: DHA (3.6 g/d)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: EPA (3.8 g/d)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Corn oil (4.0 g/d, placebo)
Number of subjects: 234
Study: 8315953

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) 5 mg/kg/day for adults, 6 mg/kg/day for children for six months, then tapered off by 25% every two months until complete discontinuation.
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Supportive therapy (control)
Number of subjects: 45
Study: 3720391

Group type: EXPERIMENTAL
Intervention: Esophageal gastric tube airway (EGTA)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Endotracheal tube (ET)
Number of subjects: 175